On Friday, September 25, the official start of the large-scale project EMPAIA takes place. The aim of the project is to establish a platform for AI-supported applications in image-based medical diagnostics. In the first round of the Artificial Intelligence (AI) innovation competition of the Federal Ministry of Economic Affairs and Energy (BMWi), EMPAIA prevailed as one of 16 platform projects among 130 submissions.

The EMPAIA consortium, led by Charité - Universitätsmedizin Berlin, intends to build a platform that gives physicians easy access to certified and validated AI solutions. For example, users should be able to compare how different programs solve a specific problem. At the same time, developers of AI algorithms should be able to access image data for the validation of their software. To accelerate the certification of algorithms for use in diagnostics, the platform will also bring together developers, reference institutes and certifiers.

Fraunhofer MEVIS focuses in the EMPAIA project especially on aspects of AI integration and AI distribution. This includes the development and establishment of technical standards together with the EMPAIA committees, the coordination of the development of the EMPAIA AI marketplace for the easy marketing of AI solutions, and the execution of research and development work in order to realize new AI solutions faster and to put them into practice.

In addition to Charité - Universitätsmedizin Berlin and Fraunhofer MEVIS, the DAI-Labor of the Technische Universität Berlin, the Vitasystems GmbH, and the initiative for quality assurance in pathology QuIP GmbH are involved in the project.

The EMPAIA consortium will introduce itself in a kickoff meeting on Friday, 25 September from 10 a.m. to 5 p.m. Media representatives are invited to attend the digital event. They are requested to register at empaia(at)charite.de.